Tele-Rehabilitation After Catheter Ablation in Patients With Atrial Fibrillation
Condition(s) studied
Investigational drug(s) / intervention(s)
Remotely Supervised Cardiac Telerehabilitation: A 12-week remotely supervised cardiac telerehabilitation exercise program consisting of aerobic, strengthening, and stretching exercises. Participants will exercise three days per week for a total of 36 sessions, with each session lasting approximately 45-60 minutes. Exercise intensity will be individually prescribed and progressed according to participant tolerance.
Usual Care and General Exercise Guidance: Participants will receive standard care and general exercise guidance. They will be encouraged to achieve 150 minutes of moderate physical activity per week but will not receive an individualized exercise training program.
Study summary
This study aims to investigate the effects of remotely supervised cardiac telerehabilitation in patients with atrial fibrillation who have undergone catheter ablation. Participants will be randomly assigned to a cardiac telerehabilitation group or a control group. The telerehabilitation group will receive a 12-week remotely supervised exercise program in addition to standard care, consisting of aerobic, strengthening, and stretching exercises. The control group will receive standard care and general exercise guidance without an individualized exercise program. Functional exercise capacity, muscle strength, arterial stiffness, heart rate variability, quality of life, physical activity, balance, cognitive function, anxiety and depression, and atrial fibrillation recurrence will be evaluated.
Eligibility
Primary outcome measure(s)
- 6 Minute Walk Test (6MWT) Distance — At baseline (1 week after catheter ablation) and within 1 week after completion of the 12-week intervention
Distance walked during the 6-minute walk test, measured in meters, as an indicator of functional exercise capacity.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Dokuz Eylul University Hospital | Izmir | Balçova |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07808307 on ClinicalTrials.gov ↗ ← All trials in Turkey